Raise ENO1-IT levels alter histone modification patterns on ENO1 and other target genes by interacting with KAT7 histone acetyltransferase, thereby altering the biological function of colorectal cancer; therefore, targeting the pathway may be advantageous in the treatment of patients with CRC (11). The gene discussed is ENO1; the disease is colorectal carcinoma.